The Th17/Treg imbalance in patients with acute coronary syndrome.

[1]  Ohad Parnes,et al.  Inflammation , 2008, The Lancet.

[2]  O. Wiklund,et al.  Dissociation of the Inflammatory Reaction following PCI for Acute Myocardial Infarction. , 2007, The Journal of invasive cardiology.

[3]  C. Tato,et al.  Distinct regulation of interleukin-17 in human T helper lymphocytes. , 2007, Arthritis and rheumatism.

[4]  Kathleen M. Smith,et al.  Development, cytokine profile and function of human interleukin 17–producing helper T cells , 2007, Nature Immunology.

[5]  P. Teeling,et al.  Low Numbers of FOXP3 Positive Regulatory T Cells Are Present in all Developmental Stages of Human Atherosclerotic Lesions , 2007, PloS one.

[6]  Hilde Cheroutre,et al.  Reciprocal TH17 and Regulatory T Cell Differentiation Mediated by Retinoic Acid , 2007, Science.

[7]  Peng Liu,et al.  The opposite-direction modulation of CD4+CD25+ Tregs and T helper 1 cells in acute coronary syndromes. , 2007, Clinical immunology.

[8]  G. Keren,et al.  Role of Naturally Occurring CD4+CD25+ Regulatory T Cells in Experimental Atherosclerosis , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[9]  Satwat Hashmi,et al.  Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease , 2006, Coronary artery disease.

[10]  G. Keren,et al.  Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. , 2006, European heart journal.

[11]  Da-zhu Li,et al.  Generation of HSP60-specific regulatory T cell and effect on atherosclerosis. , 2006, Cellular immunology.

[12]  [After TH1/TH2 now comes Treg/TH17: significance of T helper cells in immune response organization]. , 2006, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[13]  Shimon Sakaguchi,et al.  Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease , 2006, Immunological reviews.

[14]  S. Nakae,et al.  IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis1 , 2006, The Journal of Immunology.

[15]  H. Weiner,et al.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.

[16]  R. D. Hatton,et al.  Transforming growth factor-β induces development of the TH17 lineage , 2006, Nature.

[17]  R. Flavell,et al.  Natural regulatory T cells control the development of atherosclerosis in mice , 2006, Nature Medicine.

[18]  D. Littman,et al.  The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. , 2006, Cell.

[19]  R. Toes,et al.  Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. , 2005, Arthritis and rheumatism.

[20]  E. Edelman,et al.  Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes. , 2005, Journal of the American College of Cardiology.

[21]  T. Denning,et al.  Cutting Edge: CD4+CD25+ Regulatory T Cells Impaired for Intestinal Homing Can Prevent Colitis12 , 2005, The Journal of Immunology.

[22]  G. Hansson.  Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.

[23]  T. Geiger,et al.  Immunotherapy of autoimmune encephalomyelitis with redirected CD4+CD25+ T lymphocytes. , 2005, Blood.

[24]  Y. Liu,et al.  Th1/Th2 Functional Imbalance After Acute Myocardial Infarction: Coronary Arterial Inflammation or Myocardial Inflammation , 2005, Journal of Clinical Immunology.

[25]  A. Lindén,et al.  Interleukin-17 family members and inflammation. , 2004, Immunity.

[26]  D. Isenberg,et al.  Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy , 2004, The Journal of experimental medicine.

[27]  Ehrenstein,et al.  Compromised function of regulatory T cells in rheumatoid arthritis: Reversal by anti-TNF alpha therapy , 2004 .

[28]  Jeffrey A. Bluestone,et al.  In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes , 2004, The Journal of experimental medicine.

[29]  Clare Baecher-Allan,et al.  Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis , 2004, The Journal of experimental medicine.

[30]  D. Ardissino,et al.  Activation of the contact system and inflammation after thrombolytic therapy in patients with acute myocardial infarction. , 2004, The American journal of cardiology.

[31]  Z. Ungvari,et al.  Synergistic effects of vascular IL-17 and TNFalpha may promote coronary artery disease. , 2004, Medical hypotheses.

[32]  Li Li,et al.  Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 , 2003, The Journal of experimental medicine.

[33]  S. Nakae,et al.  Suppression of Immune Induction of Collagen-Induced Arthritis in IL-17-Deficient Mice 1 , 2003, The Journal of Immunology.

[34]  J. Alcocer-Varela,et al.  Quantification of regulatory T cells in patients with systemic lupus erythematosus. , 2003, Journal of autoimmunity.

[35]  Z. Ungvari,et al.  Aging‐induced proinflammatory shift in cytokine expression profile in rat coronary arteries , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  A. Andoh,et al.  Increased expression of interleukin 17 in inflammatory bowel disease , 2003, Gut.

[37]  P. Libby.  Inflammation in atherosclerosis , 2002, Nature.

[38]  Peter Libby,et al.  Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis , 2002, Circulation research.

[39]  M. Fishbein,et al.  Overexpression of Interleukin-10 by Activated T Lymphocytes Inhibits Atherosclerosis in LDL Receptor–Deficient Mice by Altering Lymphocyte and Macrophage Phenotypes , 2002, Circulation research.

[40]  Svetlana Ten,et al.  Multiple immuno-regulatory defects in type-1 diabetes. , 2002, The Journal of clinical investigation.

[41]  G. Hansson,et al.  In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. , 2001, Circulation.

[42]  U. Andersson,et al.  Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. , 1999, Atherosclerosis.

[43]  T. Martin,et al.  IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. , 1999, The Journal of clinical investigation.

[44]  P. Kivisäkk,et al.  Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis , 1999, Multiple sclerosis.

[45]  K. Kugiyama,et al.  Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. , 1986, Circulation.